Thyroid radiofrequency ablation continues to evolve through technological innovation, structured education, and global clinical collaboration. A recent training and proctorship session at Hospital del Mar in Barcelona exemplified that convergence.
The session was led by Professor Stefano Spiezia, a pioneer in thyroid thermoablation with more than 30 years of experience and founder of the Save Your Thyroid™ initiative.
During the program, Professor Spiezia presented on Cambridge RF technology to a multidisciplinary group of physicians and specialists and led three hands-on radiofrequency thermoablation procedures. He also shared insights from more than three decades in the field, along with the evolution, clinical philosophy, and international mission of the Save Your Thyroid™ initiative.
Purpose-Built for Thyroid Ablation
At the center of the session was the CRF RFA System from Cambridge Interventional, engineered specifically to support precision in thyroid ablation. Designed to create large, spherical ablation zones rapidly and consistently using a single electrode, the system enhances control and efficiency during thyroid radiofrequency ablation procedures.
Real-time audiovisual feedback, hands-free generator operation, and automated electronic logging allow clinicians to maintain focus on ultrasound guidance and patient care. The intuitive interface integrates seamlessly into existing workflows, while cooled electrode technology enhances visibility and ergonomics when treating nodules of varying size and depth.
By aligning usability with procedural performance, Cambridge RF technology supports the continued expansion of thyroid RFA as a minimally invasive alternative in appropriately indicated cases. The session reflected our ongoing focus at Cambridge Interventional on combining innovation with structured education and clinical partnership.
From Insight to Implementation
The Barcelona session translated expertise into action. Following his presentation, Professor Spiezia performed the first of three thyroid radiofrequency ablation procedures treating benign thyroid nodules.
The second procedure was completed by Dr. Salvatore Marsico under Professor Spiezia’s direct supervision, formally initiating a structured proctorship approach. A third interventional radiologist performed the final RFA thyroid nodule treatment, reinforcing how thyroid ablation can be integrated into clinical practice with structured mentorship and appropriate technology support.
By combining guided instruction with live case execution, the session demonstrated how thyroid radiofrequency ablation can be implemented confidently and reproducibly in real clinical environments.
Advancing RFA with Save Your Thyroid™
The collaboration also spotlighted Save Your Thyroid™, an international educational initiative dedicated to promoting thyroid thermal ablation as an innovative standard procedure for appropriately indicated benign nodules.
Save Your Thyroid™’s philosophy centers on preserving thyroid function while reducing unnecessary surgical interventions. By encouraging properly indicated thyroid ablation procedures, the initiative supports care pathways that may help patients avoid general anesthesia, visible scarring, and the potential long-term need for thyroid hormone replacement therapy.
Through partnerships with leaders like Professor Spiezia and institutions such as Hospital del Mar, we continue to expand awareness and adoption of minimally invasive thyroid radiofrequency ablation worldwide.
To learn how Cambridge Interventional can support the integration of thyroid radiofrequency ablation in your practice, schedule a discovery call.
Indications for use: The CRF radiofrequency ablation system of Cambridge Interventional LLC (“Cambridge”) is intended for use in percutaneous, laparoscopic and intraoperative coagulation and ablation of tissue.
Disclaimer: Read the instructions for use (“IFU”) of all medical devices prior to use. Clinical results, ablation sizes, costs, and financial/insurance coverage may vary and are not guaranteed. The information contained in the multimedia content that is posted on the Cambridge Interventional website or that references or links to this text (“Content”) is for general informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment; standards of medical care or training; or the instructions, indications, and contraindications for use of Cambridge Interventional devices or any other medical devices. All information is provided in good faith, however Cambridge makes no representation or warranty of any kind, express or implied regarding the accuracy, applicability, fitness, or completeness of this information; of opinions expressed; of third-party publications referenced or summarized; or of third-party services presented. Always seek the advice of your physician about a medical condition. Never disregard professional medical advice, or delay in seeking it, because of something you have read or seen in this Content.
Adverse events: Reported adverse events or complications for RF ablation or coagulation procedures include, but are not limited to, the following (the long-term risks of RF ablations have not been established): abscess, ARDS (acute respiratory distress syndrome), arrhythmia, ascites, atrial fibrillation, bile duct injury, bile leakage, biliary fistula, biloma, bleeding, bone degeneration, bone fracture, bronchial occlusion, bronchopleural fistula, burn, cardiac arrhythmia, cardiac ischemia, chest tube, coughing, death, delayed hemorrhage into ablated tissue, device failure, device fracture in patient, diaphragm injury, diarrhea, edema, electric shock, emphysema, fever, fistula, hematoma, hematuria, hemoglobinuria, hemoptysis, hemorrhage, hemothorax, hoarseness, hypertension, hyperthyroidism, hypoesthesia, hypotension, hypothyroidism, infection, kidney atrophy, liver failure, liver insufficiency, multiple sclerosis exacerbation, muscle burn, muscle contracture, nausea/vomiting, nerve injury, neuropathy, nodule rupture, organ damage, pain, paresthesia, perforated colon, perforation, peritonitis, pes equinus injury, pleural effusion, pneumonia, pneumothorax, renal failure, skin burn, tumor recurrence, tumor seeding, urinary fistula, urinary incontinence, urinary retention, urine leakage, vasovagal reaction, vessel injury, vocal cord palsy, voice change, wound discharge. RF ablation procedures are not recommended for pregnant patients. Potential risks to the patient and/or fetus have not been established. General clinical residual risks for surgical procedures include anesthesia reaction, bleeding, blood clots, death, infection, organ injury, pain, and necessity for more invasive surgery, including open surgery, if complications occur.
